Thomas A Mccourt - Net Worth and Insider Trading
Thomas A Mccourt Net Worth
The estimated net worth of Thomas A Mccourt is at least $6 Million dollars as of 2024-11-05. Thomas A Mccourt is the CEO of Ironwood Pharmaceuticals Inc and owns about 1,150,330 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $5 Million. Thomas A Mccourt is also the Director of Acceleron Pharma Inc and owns about 6,044 shares of Acceleron Pharma Inc (XLRN) stock worth over $1 Million. Details can be seen in Thomas A Mccourt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas A Mccourt has not made any transactions after 2024-05-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas A Mccourt
Thomas A Mccourt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas A Mccourt owns 3 companies in total, including Acceleron Pharma Inc (XLRN) , Ironwood Pharmaceuticals Inc (IRWD) , and Pliant Therapeutics Inc (PLRX) .
Click here to see the complete history of Thomas A Mccourt’s form 4 insider trades.
Insider Ownership Summary of Thomas A Mccourt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XLRN | Acceleron Pharma Inc | 2021-04-19 | director |
| IRWD | Ironwood Pharmaceuticals Inc | 2024-05-20 | Chief Commercial Officer |
| PLRX | Pliant Therapeutics Inc | 2023-03-06 | director |
Thomas A Mccourt Latest Holdings Summary
Thomas A Mccourt currently owns a total of 2 stocks. Among these stocks, Thomas A Mccourt owns 1,150,330 shares of Ironwood Pharmaceuticals Inc (IRWD) as of May 20, 2024, with a value of $5 Million and a weighting of 81.69%. Thomas A Mccourt also owns 6,044 shares of Acceleron Pharma Inc (XLRN) as of April 19, 2021, with a value of $1 Million and a weighting of 18.31%.
Latest Holdings of Thomas A Mccourt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 2024-05-20 | 1,150,330 | 4.19 | 4,819,883 |
| XLRN | Acceleron Pharma Inc | 2021-04-19 | 6,044 | 178.75 | 1,080,365 |
Holding Weightings of Thomas A Mccourt
Thomas A Mccourt Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas A Mccourt has made a total of 19 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 67,618 shares on May 20, 2024, which brought Thomas A Mccourt around $436,136.
According to the SEC Form 4 filings, Thomas A Mccourt has made a total of 2 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Acceleron Pharma Inc is the sale of 7,500 shares on April 19, 2021, which brought Thomas A Mccourt around $894,450.
Insider Trading History of Thomas A Mccourt
- 1
Thomas A Mccourt Trading Performance
Thomas A Mccourt Ownership Network
Ownership Network List of Thomas A Mccourt
Ownership Network Relation of Thomas A Mccourt
Thomas A Mccourt Owned Company Details
What does Acceleron Pharma Inc do?
Who are the key executives at Acceleron Pharma Inc?
Thomas A Mccourt is the director of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .
Acceleron Pharma Inc (XLRN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acceleron Pharma Inc Insider Transactions
Thomas A Mccourt Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas A Mccourt. You might contact Thomas A Mccourt via mailing address: C/o Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
